Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Claris Ventures SGR is a venture capital firm based in Italy, founded in 2019. The firm specializes in early-stage investments in biopharma companies, managing funds like Claris Biotech I and II. Claris Ventures focuses on supporting companies that emerge from the Italian research and development ecosystem.
Claris Ventures specializes in equity investments in early-stage biopharma companies, particularly in oncology, immunology, and rare diseases. The firm invests in seed and Series A rounds, providing capital and hands-on support to facilitate clinical development programs. Their approach emphasizes creating value based on clinical evidence.
Notable portfolio companies include Kither Biotech, which develops drugs for respiratory diseases, and NeoPhore, focused on cancer immunotherapies. Other companies include Heqet Therapeutics, Iama Therapeutics, and Sibylla Biotech, among others.
Email info@clarisventures.com with your deck to pitch them.
As of October 2023: Claris Ventures recently supported Haptena Therapeutics in securing €3 million in seed financing to develop treatments for KRAS-driven cancers.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.